Rain Oncology (RAIN) Stock Price, News & Analysis

Company Overview

As of January 26, 2024, operates as a subsidiary of Pathos AI, Inc.

Key Stats

• Today's Range: $4.04 to $4.43
• 50-Day Range: $1.20 to $1.24
• 52-Week Range: $0.82 to $11.32
• Volume: 32,615 shs
• Average Volume: 32,376 shs
• Market Capitalization: $24.27 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RAIN Stock Analysis - Frequently Asked Questions

How were Rain Oncology's earnings last quarter?

Rain Oncology Inc. (NASDAQ:RAIN) released its earnings results on Thursday, May, 15th. The company reported ($0.20) EPS for the quarter.

When did Rain Oncology IPO?

Rain Oncology (RAIN) raised $126 million in an initial public offering (IPO) on Friday, April 23rd 2021. The company issued 7,400,000 shares at $16.00-$18.00 per share. Goldman Sachs, Citigroup, Piper Sandler and Guggenheim Securities served as the underwriters for the IPO.

Who are Rain Oncology's major shareholders?

Top institutional investors of Rain Oncology include Polar Asset Management Partners Inc. (0.52%) and Apollo Management Holdings L.P. (0.43%). Insiders that own company stock include Bvf Partners L P/Il, Boxer Capital, Llc, Franklin M Berger and Paul T Dacier.
View institutional ownership trends.

What other stocks do shareholders of Rain Oncology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Rain Oncology investors own include CRISPR Therapeutics (CRSP), Meta Platforms (META), UiPath (PATH), Recursion Pharmaceuticals (RXRX), Alibaba Group (BABA), NVIDIA (NVDA) and

Company Calendar

• Last Earnings: 5/15/2025
• Today: 5/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Holding & other investment offices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:RAIN
• CIK: 1724979
• Web: www.rainthera.com
• Phone: 510-953-5559
• Fax: N/A
• Employees: 63
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $3.10 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -9.51%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.01
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.59 per share
• Price / Cash Flow: 7.41
• Book Value: ($0.69) per share
• Price / Book: -6.35

Miscellaneous

• Outstanding Shares: 5,540,000
• Free Float: 4,574,000
• Market Cap: $24.27 million
• Optionable: No Data
• Beta: -0.11